Get started
111

ENSOL BIOSCIENCES

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

140610 chart


Full chart

Key stats


Market capitalization
‪139.25 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−11.30 B‬ KRW
Revenue (FY)
‪176.54 M‬ KRW
Shares float
‪9.86 M‬
Beta (1Y)
−0.31

Employees


Employees (FY)
41
Change (1Y)
−1 −2.38%
Revenue / Employee (1Y)
‪3.31 K‬ KRW
Net income / Employee (1Y)
‪−211.71 K‬ KRW

About ENSOL BIOSCIENCES


Sector
Distribution Services
Industry
Medical Distributors
CEO
Hae-Jin Kim
Website
ensolbio.co.kr
Headquarters
Daejeon
Founded
2001
ISIN
KR7140610007
FIGI
BBG00LWWQ044
Ensol Biosciences, Inc. manufactures and sells drugs. The firm develops BT·IT convergence technology (the core bioinformatics technology) such as in-silico genome analysis system, transcriptome analysis system, proteome analysis system and metabolome analysis system. It has been investing in developing bio-hydrogen energy, bio-environments, bio-foods and bio-cosmetics. The company was founded by Hae-Jin Kim on February 20, 2001 and is headquartered in Daejeon, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 140610 is 12,550 KRW — it has decreased by −0.70% in the past 24 hours. Watch ENSOL BIOSCIENCES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ENSOL BIOSCIENCES stocks are traded under the ticker 140610.
140610 stock has fallen by −4.07% compared to the previous week, the month change is a 10.61% rise, over the last year ENSOL BIOSCIENCES has showed a 42.73% increase.
140610 reached its all-time high on Feb 10, 2021 with the price of 22,950 KRW, and its all-time low was 2,800 KRW and was reached on Mar 22, 2024. View more price dynamics on 140610 chart.
See other stocks reaching their highest and lowest prices.
140610 stock is 8.11% volatile and has beta coefficient of −0.31. Track ENSOL BIOSCIENCES stock price on the chart and check out the list of the most volatile stocks — is ENSOL BIOSCIENCES there?
Today ENSOL BIOSCIENCES has the market capitalization of ‪139.36 B‬, it has decreased by −1.16% over the last week.
Yes, you can track ENSOL BIOSCIENCES financials in yearly and quarterly reports right on TradingView.
No, 140610 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 41.00 employees. See our rating of the largest employees — is ENSOL BIOSCIENCES on this list?
Like other stocks, 140610 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENSOL BIOSCIENCES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENSOL BIOSCIENCES technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENSOL BIOSCIENCES stock shows the buy signal. See more of ENSOL BIOSCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.